Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Schrimpf

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Acta Neuropathologica|April 25, 2018
Novel, improved grading system(s) for IDH-mutant astrocytic gliomasMitsuaki Shirahata, Takahiro Ono, Damian Stichel, et al.
Neuro-Oncology|December 22, 2025
Molecular and Clinical Stratification of Astroblastomas: Three distinct Fusion-Defined Groups Informing Risk-Adapted Treatment StrategiesAniello Federico, Felix Schmitt-Hoffner, Adriana Fonseca, et al.
Acta Neuropathologica|February 3, 2025
IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spreadFelix Hinz, Dennis Friedel, Andrey Korshunov, et al.
The Lancet. Oncology|March 19, 2017
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysisFelix Sahm, Daniel Schrimpf, Damian Stichel, et al.
Acta Neuropathologica|March 18, 2023
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusionsHenri Bogumil, Martin Sill, Daniel Schrimpf, et al.
Acta Neuropathologica|September 30, 2019
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease courseAnnika K Wefers, Damian Stichel, Daniel Schrimpf, et al.
Acta Neuropathologica|March 23, 2018
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterationsAnnekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, et al.
Nature Cancer|June 10, 2026
Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypesDarui Jin, Artem Shmatko, Areeba Patel, et al.
Nature Medicine|July 11, 2018
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarateLukas Bunse, Stefan Pusch, Theresa Bunse, et al.
Nature Medicine|March 26, 2025
Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumorsAreeba Patel, Kirsten Göbel, Sebastian Ille, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Acta Neuropathologica|April 25, 2018
Novel, improved grading system(s) for IDH-mutant astrocytic gliomasMitsuaki Shirahata, Takahiro Ono, Damian Stichel, et al.
Neuro-Oncology|December 22, 2025
Molecular and Clinical Stratification of Astroblastomas: Three distinct Fusion-Defined Groups Informing Risk-Adapted Treatment StrategiesAniello Federico, Felix Schmitt-Hoffner, Adriana Fonseca, et al.
Acta Neuropathologica|February 3, 2025
IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spreadFelix Hinz, Dennis Friedel, Andrey Korshunov, et al.
The Lancet. Oncology|March 19, 2017
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysisFelix Sahm, Daniel Schrimpf, Damian Stichel, et al.
Acta Neuropathologica|March 18, 2023
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusionsHenri Bogumil, Martin Sill, Daniel Schrimpf, et al.
Acta Neuropathologica|September 30, 2019
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease courseAnnika K Wefers, Damian Stichel, Daniel Schrimpf, et al.
Acta Neuropathologica|March 23, 2018
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterationsAnnekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, et al.
Nature Cancer|June 10, 2026
Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypesDarui Jin, Artem Shmatko, Areeba Patel, et al.
Nature Medicine|July 11, 2018
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarateLukas Bunse, Stefan Pusch, Theresa Bunse, et al.
Nature Medicine|March 26, 2025
Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumorsAreeba Patel, Kirsten Göbel, Sebastian Ille, et al.
Pageof 13